NexturnBioscience Co., Ltd announced a private placement of 3,655,351 shares at an issue price of KRW 3,830 per share for proceeds of KRW 13,999,994,330 on March 31, 2022. The transaction has been approved by the board of directors. The transaction is expected to close on May 31, 2022.

the shares are subject to a hold period of 1 year. The transaction will include participation from Santa Claus Investment Consortium for 3,394,255 shares and JP Fund for 261,096 shares.